Previous Close | 1.74 |
1-Year Change | 40.32% |
6-Months Change | -20.55% |
3-Months Change | -24.02% |
Moving Avg (50d) | 2.0316 |
Moving Avg (200d) | 2.2616 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 194.7M |
Beta (3-Years) | 0.91 |
Revenue Growth (ttm) | 42.8% |
Net Profit Margin (ttm) | -202.51% |
Return On Assets (ttm) | -94.16% |
EPS (ttm) | -2.36 |
PE Ratio (ttm) | -0.74 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |